NDUFB9P1

Across TCGA pan-cancer cohorts, NDUFB9P1 RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of NDUFB9P1’s most consistent transcriptional readouts.

The strongest signal is observed in breast invasive carcinoma (BRCA), where NDUFB9P1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types NDUFB9P1 is over-expressed in tumor, although a few such as KIRP show the opposite, repressed pattern.

BRCA, CHOL, and LUAD are the cancer types where NDUFB9P1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in NDUFB9P1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
BRCA	Female	All	+0.103	.034	2	view →
CHOL	All	All	+0.116	.029	1	view →
LUAD	All	All	+0.108	.045	1	view →
KIRP	Female	All	−0.074	.049	1	view →
HNSC	All	All	+0.037	.041	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

NDUFB9P1–BRCA

Open the BRCA breakdown →